IBRX

ImmunityBio
IBRX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$2.37B
EV
$3.01B
Shares Outstanding
882.47M
Beta
-0.13

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$13.00
P/E 2025E
-
P/Revenue 2025E
22.67x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ImmunityBio, Inc.

gainify
IBRX

ImmunityBio, Inc.

IBRX

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Its platforms for the development of biologic product candidates include antibody-...

Sector

Healthcare

Industry

Biotechnology

CEO

Adcock, Richard

Employees

680

IPO Date

2015-07-28

Headquarters

3530 John Hopkins Court, San Diego, California, 92121, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved